C2NLDx Impact Summary Report 2024
Sector insightsAn overview of the achievements, outcomes and legacy of MedCity’s Collaborate to Innovate: London Diagnostics Programme.
Overview
The C2NLDx Impact Summary Report presents the key achievements and legacy of the Collaborate to Innovate: London Diagnostics Programme. The initiative, delivered by MedCity and evaluated independently by KADA Research, supported collaboration between diagnostics companies, academia and the NHS. The report shows how the programme helped companies bring new technologies to market, strengthen research partnerships and improve patient access to innovation. It also reflects on the lessons that shaped future MedCity programmes, confirming London’s global position in diagnostics excellence.
C2NLDx demonstrates the value of strategic coordination, transparent evaluation and cross-sector partnership in building a thriving diagnostics ecosystem.
Key takeaways
- Collaboration delivers resultsThe programme supported more than 40 collaborations between diagnostics SMEs, academic groups and NHS trusts, accelerating innovation and adoption.
- Investment and evaluation built confidenceTargeted funding and independent evaluation created an evidence base for success, giving partners and investors confidence in the diagnostics ecosystem.
- A model for future programmesC2NLDx set a template for regional innovation clusters that align healthcare, research and industry around shared goals for patient benefit.
